{"id":870,"date":"2026-10-20T03:13:08","date_gmt":"2026-10-20T01:13:08","guid":{"rendered":"http:\/\/novameds.local\/es\/?post_type=product&#038;p=870"},"modified":"2026-10-20T03:59:36","modified_gmt":"2026-10-20T01:59:36","slug":"catalog-cjc-1295-with-dac-2mg","status":"publish","type":"product","link":"https:\/\/novameds.health\/es\/producto\/catalog-cjc-1295-with-dac-2mg\/","title":{"rendered":"CJC-1295 with DAC, 2mg"},"content":{"rendered":"<section id=\"composition\" data-nav=\"Composici\u00f3n y detalles del producto\">\n<h2>Composici\u00f3n y detalles del producto<\/h2>\n<div class=\"nm-catalog-document\">\n<div>\n<h2>Descripci\u00f3n<\/h2>\n<div>\n<p>CJC-1295 with DAC is a synthetic modified peptide compound studied for its interactions with growth hormone-releasing hormone (GHRH) receptor pathways in experimental models.<\/p>\n<p>The Drug Affinity Complex (DAC) modification \u2014 a maleimidopropionyl-lysine moiety at the C-terminus \u2014 is studied for its capacity to reversibly bind albumin in experimental systems, producing extended stability compared to the unmodified CJC-1295 variant.<\/p>\n<p>The compound is designed with a 30-amino acid sequence structure incorporating four amino acid substitutions that confer enhanced protease resistance relative to native GHRH(1-29). Research applications include GHRH receptor pathway studies, growth hormone secretagogue signalling research, and comparative DAC-modified versus unmodified peptide pharmacology.<\/p>\n<ul>\n<li> <span><b>High Purity<\/b> \u2013 99% Purity Guaranteed<\/span><\/li>\n<li> Independently Lab Tested<\/li>\n<li> Research Grade Quality<\/li>\n<li> For Laboratory Research Use Only<\/li>\n<\/ul><\/div>\n<div>\n<p><a href=\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/91971820\" target=\"_blank\" rel=\"noopener noreferrer\">Datos moleculares en PubChem<\/a><\/p>\n<\/p><\/div>\n<\/p><\/div>\n<div>\n<h2>Propiedades<\/h2>\n<div class=\"nm-catalog-table\" tabindex=\"0\" role=\"region\" aria-label=\"Product data\">\n<table>\n<tbody>\n<tr>\n<th>Chemical Formula<\/th>\n<td>C165H269N47O46<\/td>\n<\/tr>\n<tr>\n<th>Synonyms<\/th>\n<td>CJC1295 With DAC, 446262-90-4<\/td>\n<\/tr>\n<tr>\n<th>Molar Mass<\/th>\n<td>3647.2 g\/mol<\/td>\n<\/tr>\n<tr>\n<th>CAS Number<\/th>\n<td>446262-90-4<\/td>\n<\/tr>\n<tr>\n<th>PubChem CID<\/th>\n<td>91971820<\/td>\n<\/tr>\n<tr>\n<th>Formatos disponibles<\/th>\n<td>Vial \u00b7 KIT (10 vials)<\/td>\n<\/tr>\n<tr>\n<th>Shelf Life<\/th>\n<td>36 months<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div><\/div>\n<div>\n<h2>Investigaci\u00f3n<\/h2>\n<p>\t\t\t\t\t<span>CJC-1295 with DAC is a synthetic 30-amino acid GHRH analogue studied for selective receptor affinity and extended stability in laboratory research models. The compound incorporates four amino acid substitutions (D-Ala2, Gln8, Ala15, Leu27) that confer enhanced protease resistance relative to native GHRH(1-29), and a Drug Affinity Complex (DAC) modification at the C-terminus studied for its capacity to reversibly bind albumin in experimental systems, producing significantly extended peptide stability relative to the non-DAC CJC-1295 variant. Laboratory research has examined its growth hormone secretagogue signalling properties \u2014 including proposed modulation of pituitary GHRH receptor pathways and downstream IGF-1 axis signalling \u2014 in cell-based and in vivo experimental models. Comparative research protocols frequently pair CJC-1295 with DAC against the non-DAC variant to characterise the contribution of the albumin-binding modification to receptor engagement duration and downstream signalling profiles. Independently third-party HPLC-tested; COA available per batch.<\/span>\t\t\t\t\t<\/div>\n<div>\n<h2>FAQ<\/h2>\n<div>\n<details>\n<summary>\n\t\t\t\t\t\t\t\t\t\t<span>What is the Drug Affinity Complex (DAC) modification and how does it affect CJC-1295&#8217;s stability in research models?<\/span><\/p>\n<\/summary>\n<div>\n<p> The DAC modification in CJC-1295 is a maleimidopropionyl-lysine moiety incorporated at the C-terminus of the peptide sequence, studied for its capacity to reversibly bind cysteine-34 of albumin in experimental systems. This albumin-binding interaction is studied for its role in significantly extending the peptide&#8217;s stability in biological research models relative to the non-DAC CJC-1295 variant, making the DAC form a standard research tool in protocols requiring sustained receptor pathway engagement over extended experimental timelines.<\/p>\n<\/div>\n<\/details>\n<details>\n<summary>\n\t\t\t\t\t\t\t\t\t\t<span>How do the four amino acid substitutions in CJC-1295 differ from native GHRH(1-29)?<\/span><\/p>\n<\/summary>\n<div>\n<p>CJC-1295 incorporates D-Ala at position 2, Gln at position 8, Ala at position 15, and Leu at position 27 relative to native GHRH(1-29), substitutions studied for their capacity to confer enhanced resistance to proteolytic degradation while preserving GHRH receptor binding affinity. These modifications are examined in comparative structure-activity research contrasting CJC-1295&#8217;s stability and receptor binding profile against native GHRH(1-29) and other GHRH analogues.<\/p>\n<\/div>\n<\/details>\n<details>\n<summary>\n\t\t\t\t\t\t\t\t\t\t<span>What advantages does the 10-vial KIT format provide for extended research programs?<\/span><\/p>\n<\/summary>\n<div>\n<p>The 10-vial KIT format is particularly useful for longitudinal investigations, repeated-dose studies, multi-arm experimental designs, pharmacokinetic research, and chronic pathway-signaling programs requiring consistent compound availability across multiple study phases.<\/p>\n<p>Individually sealed vials allow compound to remain lyophilized until needed, supporting stability throughout extended research timelines. The use of matched-batch material across all ten vials also helps minimize variability between experimental sessions, making the KIT format well suited to long-duration receptor-signaling and comparative pharmacology studies.<\/p>\n<\/div>\n<\/details><\/div>\n<\/p><\/div>\n<\/div>\n<\/section>\n","protected":false},"excerpt":{"rendered":"<p>CJC-1295 with DAC is a synthetic modified peptide compound studied for its interactions with growth hormone-releasing hormone (GHRH) receptor pathways in experimental models.<\/p>\n<p>Presentaci\u00f3n: CJC-1295 with DAC, 2mg.<\/p>\n<p>Seleccione la concentraci\u00f3n y el tama\u00f1o del envase.<\/p>\n<p class=\"nm-research-disclaimer\">Solo para investigaci\u00f3n de laboratorio. No apto para uso humano o veterinario.<\/p>\n<p class=\"nm-catalog-image-note\"><small>Envase ilustrativo generado con IA.<\/small><\/p>\n","protected":false},"featured_media":1038,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[25],"product_tag":[],"nm_classification":[],"class_list":["post-870","product","type-product","status-publish","has-post-thumbnail","product_cat-hormonal-health-growth","first","instock","shipping-taxable","purchasable","product-type-variable","has-default-attributes"],"_links":{"self":[{"href":"https:\/\/novameds.health\/es\/wp-json\/wp\/v2\/product\/870","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/novameds.health\/es\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/novameds.health\/es\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/novameds.health\/es\/wp-json\/wp\/v2\/comments?post=870"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/novameds.health\/es\/wp-json\/wp\/v2\/media\/1038"}],"wp:attachment":[{"href":"https:\/\/novameds.health\/es\/wp-json\/wp\/v2\/media?parent=870"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/novameds.health\/es\/wp-json\/wp\/v2\/product_brand?post=870"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/novameds.health\/es\/wp-json\/wp\/v2\/product_cat?post=870"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/novameds.health\/es\/wp-json\/wp\/v2\/product_tag?post=870"},{"taxonomy":"nm_classification","embeddable":true,"href":"https:\/\/novameds.health\/es\/wp-json\/wp\/v2\/nm_classification?post=870"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}